Testing effectiveness (Phase 2)UnknownNCT05252403
What this trial is testing
Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL
Who this might be right for
Acute Lymphoblastic Leukemia
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 35